✦ LIBER ✦

Sulphasalazine in rheumatoid arthritis: Combination therapy with D-penicillamine or sodium aurothiomalate

✍ Scribed by M. Farr; G. Kitas; P. A. Bacon

Publisher: Springer
Year: 1988
Tongue: English
Weight: 427 KB
Volume: 7
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02204462

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA antigens and adverse drug reactions

HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis

✍ S. Rantapää Dahlqvist; H. Ström; A. Bjelle; E. Möller 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 461 KB

Association of HLA-Bw35 with mucocutaneo

Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy

✍ Hubert G. Nüsslein; Helga Jahn; Georg Lösch; Irene Guggenmoos-Holzmann; Wolfgang 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

Microalbuminuria in rheumatoid arthritis

Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation

✍ Dimitrios Daoussis; Vasileios F. Panoulas; Holly John; Tracey E. Toms; Ioannis A 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 148 KB

Decreased pokeweed mitogen-induced igm a

Decreased pokeweed mitogen-induced igm and igm rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine

✍ Nancy J. Olsen; Hugo E. Jasin 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 873 KB

Interleukin-6 receptor inhibition with t

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The PREMIER study: A multicenter, random

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

✍ Ferdinand C. Breedveld; Michael H. Weisman; Arthur F. Kavanaugh; Stanley B. Cohe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views